MedTech
The company, which specialises in the treatment of vertigo, plans to use the funding to expand further into Britain and the US
Vertigenius, an Irish medtech company which specialises in the treatment of vertigo, has raised over €2.1 million in seed funding.
The investment will enable Vertigenius to create 10 new jobs and fund its expansion into key markets in Britain and the US, the company said.
Atlantic Bridge, the Irish growth equity investment firm, led the funding round, which also saw investment from Ascentifi and Enterprise Ireland.
According to Vertigenius, the company’s software is currently being …